We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
426
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$78.9K 0.01%
2,631
+275
+12% +$9.11K
XBI icon
427
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$77.7K 0.01%
608
– –
LYEL icon
428
Lyell Immunopharma
LYEL
$347M
$75.6K 0.01%
3,770
+313
+9% +$7.32K
AURA icon
429
Aura Biosciences
AURA
$802M
$75.4K 0.01%
11,269
+921
+9% +$5.29K
RGNX icon
430
Regenxbio
RGNX
$720M
$75.3K 0.01%
8,983
+734
+9% +$7.71K
AVIR icon
431
Atea Pharmaceuticals
AVIR
$405M
$74.6K 0.01%
13,864
+1,133
+9% +$5.2K
LXEO icon
432
Lexeo Therapeutics
LXEO
$382M
$74.3K 0.01%
12,952
+1,059
+9% +$7.5K
MRVI icon
433
Maravai LifeSciences
MRVI
$861M
$73.5K 0.01%
25,977
+2,346
+10% +$7.95K
SRZN icon
434
Surrozen
SRZN
$284M
$72.8K 0.01%
2,500
+1,000
+67% +$24K
VNDA icon
435
Vanda Pharmaceuticals
VNDA
$314M
$72.5K 0.01%
10,489
+859
+9% +$6.62K
EPRX
436
Eupraxia Pharmaceuticals
EPRX
$423M
$72.4K 0.01%
+10,000
New +$80.5K
SIVR icon
437
abrdn Physical Silver Shares ETF
SIVR
$4.53B
$71.6K 0.01%
1,000
-2,000
-67% -$160K
PACB icon
438
Pacific Biosciences
PACB
$345M
$70.7K 0.01%
53,592
+4,396
+9% +$7.86K
CAMP icon
439
CAMP4 Therapeutics
CAMP
$284M
$70.6K 0.01%
16,000
+6,000
+60% +$28.5K
ATEC icon
440
Alphatec Holdings
ATEC
$1.49B
$69.6K 0.01%
6,400
+1,400
+28% +$20.4K
RCKT icon
441
Rocket Pharmaceuticals
RCKT
$374M
$69K 0.01%
19,266
+1,631
+9% +$6.48K
ALT icon
442
Altimmune
ALT
$570M
$68.4K 0.01%
22,223
+5,220
+31% +$22.2K
SLV icon
443
iShares Silver Trust
SLV
$31.8B
$68.1K 0.01%
1,000
-22,000
-96% -$1.67M
SIGA icon
444
SIGA Technologies
SIGA
$206M
$68K 0.01%
12,708
+1,039
+9% +$6.48K
ENTA icon
445
Enanta Pharmaceuticals
ENTA
$393M
$65K ﹤0.01%
5,150
+447
+10% +$5.99K
CADL icon
446
Candel Therapeutics
CADL
$783M
$63.7K ﹤0.01%
12,998
+4,052
+45% +$22.1K
IMRX icon
447
Immuneering
IMRX
$328M
$60.4K ﹤0.01%
11,458
-4,064
-26% -$20.8K
KROS icon
448
Keros Therapeutics
KROS
$222M
$59.7K ﹤0.01%
5,406
+442
+9% +$6.83K
NMRA icon
449
Neumora Therapeutics
NMRA
$317M
$57.8K ﹤0.01%
29,651
+2,424
+9% +$6.28K
PBYI icon
450
Puma Biotechnology
PBYI
$459M
$57.7K ﹤0.01%
9,028
+817
+10% +$5.27K
16 17
18
19 20

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.